← Back to Search

Diazepam for Postoperative Pain

Phase 4
Waitlist Available
Led By Rachel Pauls, MD
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 3.5 and 6 hours postoperatively
Awards & highlights

Study Summary

This trial will study whether the use of rectal diazepam suppositories can decrease postoperative pain after major vaginal pelvic organ prolapse surgery.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 3.5 and 6 hours postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and between 3.5 and 6 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vaginal/Rectal pain in Visual Analogue Scale (VAS) score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Diazepam groupExperimental Treatment1 Intervention
Rectal Diazepam suppository
Group II: Placebo groupPlacebo Group1 Intervention
Placebo suppository
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diazepam
FDA approved

Find a Location

Who is running the clinical trial?

TriHealth Inc.Lead Sponsor
95 Previous Clinical Trials
50,838 Total Patients Enrolled
2 Trials studying Postoperative Pain
496 Patients Enrolled for Postoperative Pain
Rachel Pauls, MDPrincipal InvestigatorTriHealth - Cincinnati Urogynecology Associates
23 Previous Clinical Trials
25,885 Total Patients Enrolled
2 Trials studying Postoperative Pain
496 Patients Enrolled for Postoperative Pain

Frequently Asked Questions

~25 spots leftby Apr 2025